Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
“ATP level increase” refers broadly to any process resulting in higher concentrations of adenosine triphosphate within cells or tissues. This outcome can arise from enhanced activity of enzymes like ATP synthase, improved mitochondrial function, upregulated glycolysis, or decreased consumption/degradation. While increasing intracellular ATP generally supports cell survival and function by providing more chemical energy for biological processes, elevated extracellular levels serve as signals through purinergic receptors—P2X ion channels and P2Y G-protein-coupled receptors—which mediate diverse physiological responses including inflammation and vascular tone regulation. Because this term does not specify any one protein or pathway but instead denotes an effect achievable through multiple mechanisms and targets, it should not be treated as a canonical drug target itself.
Mechanisms leading to increased cellular/extracellular ATP include: Stimulation of oxidative phosphorylation via electron transport chain/mitochondrial function; Activation of glycolysis; Modulation of purinergic signaling pathways.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP level increase.